The BioTek Cytation 9 cell imaging multimode reader offers researchers a comprehensive and cost-effective platform to support high content analysis and live cell imaging capabilities for a diverse set of applications. By combining inverted fluorescence microscopy, upright imaging, and a multimode microplate reader module, the system is designed to support both biochemical and cell-based assays in a single instrument. The result is a unified platform that helps laboratories consolidate assays, expand imaging options, and move from samples to analyzed results more efficiently.
Drawing on over a decade of innovation and ongoing customer feedback, BioTek Cytation 9 is the newest addition to the BioTek Cytation portfolio and the latest step in Agilent’s effort to combine multimode microplate reading with high-content cell imaging. Introduced in 2013, the BioTek Cytation portfolio has served as an industry standard for this combined approach, and Cytation 9 extends that foundation with expanded imaging capabilities and advanced hybrid microplate detection technologies. The system is designed for researchers who need a single platform that can address a broad range of workflows without sacrificing flexibility.
A major advantage of Cytation 9 is its ability to streamline discovery workflows. Rather than relying on separate systems for diverse applications, labs can consolidate assays onto one comprehensive platform that supports both biochemical and cell-based assays. Expanded image-cube capacity and enhanced optics help capture more data per well, giving researchers richer cellular insights. Faster imaging throughput also supports a more efficient path from raw samples to analyzed results, which can be especially valuable in busy research environments.
The system is designed to support kinetic studies and live-cell workflows. Software-controlled gas modules help maintain a stable, monitored environment for live-cell studies, supporting superior kinetic data collection. For labs that need to adapt over time, the modular design allows the addition of new imaging modes when needed, making the platform ready for new assay demands as research evolves.
Cytation 9 is suited to diverse workflows ranging from biochemical-based assays to automated live cell kinetic assays. Its applications include cell health and viability, spot counting, neurite outgrowth, ELISpot imaging, and 3D model and whole organism imaging. This broad application range makes the instrument useful across basic research, high-content screening, and more rigorous research demands in pharmaceutical and biotechnology labs.
The versatile Cytation 9 has a broader application range and twice the imaging speed of its predecessors and will help accelerate the next wave of discoveries in cell biology and drug development.